Aromasin 25 – Xeno Labs USA

Aromasin 25 – Xeno Labs USA

Aromasin (Exemestane) is a potent, irreversible Aromatase Inhibitor (AI) designed to drastically decrease the amount of estrogen the body produces. While primarily applied in the medical field to treat certain types of breast cancer in postmenopausal women and prevent the cancer from returning, its efficiency in suppressing estrogen makes it highly valued for specialized applications.

This medication helps to decrease the possibilities of reverse growth of breast cancer and is fruitful in decreasing estrogen levels in women whose cancer has progressed despite other treatments.

Key Benefits & Product Details

• Potent Estrogen Suppression: Aromasin is highly beneficial for rapidly and effectively decreasing circulating estrogen levels in the body.

• Irreversible Action: Unlike reversible AIs, Exemestane is a “Suicidal” AI; it permanently disables the aromatase enzyme, ensuring robust and lasting estrogen control throughout the 6–10 week duration of use.

• Cancer Support: Applied medically to treat and prevent the recurrence of specific breast cancer types in women after menopause.

• Convenient Oral Format: Easy administration via tablets.